<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000663324">
  <TermName>tipranavir sodium</TermName>
  <TermPronunciation>(tih-PRA-nuh-veer SOH-dee-um)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A drug used with another drug, ritonavir, to treat patients who are infected with HIV (the virus that causes AIDS) and have been treated with other anti-HIV drugs. Tipranavir sodium blocks the HIV virus from making copies of itself. It is a type of anti-HIV agent and a type of protease inhibitor. Also called Aptivus.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000725873" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;tipranavir sodium&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000725872" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;tipranavir sódico&quot;" language="es" id="_4"/>
  <SpanishTermName>tipranavir sódico</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Medicamento que se usa con otro medicamento, ritonavir, para el tratamiento de los pacientes infectados por el VIH (virus que causa el SIDA),  que ya se trataron con otros medicamentos contra el VIH. El tipranavir sódico impide que el VIH haga copias de sí mismo. Es un tipo de medicamento contra el VIH y de inhibidor de la proteasa. También se llama Aptivus.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2010-05-26</DateFirstPublished>
</GlossaryTerm>
